Smoldering Multiple Myeloma
Showing 26 - 50 of >10,000
Smoldering Plasma Cell Myeloma Trial in Houston (procedure, drug, biological)
Recruiting
- Smoldering Plasma Cell Myeloma
- Biopsy Specimen Radiography
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Nov 12, 2021
Plasma Cell Myeloma, Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Phoenix, Jacksonville, Rochester
Recruiting
- Plasma Cell Myeloma
- +3 more
- Bone Marrow Biopsy
- +3 more
-
Phoenix, Arizona
- +2 more
Jan 18, 2023
Smoldering Myeloma, Smoldering Multiple Myeloma Trial in United States (Elotuzumab, Lenalidomide, Dexamethasone)
Active, not recruiting
- Smoldering Myeloma
- Smoldering Multiple Myeloma
- Elotuzumab
- +2 more
-
Denver, Colorado
- +8 more
Nov 1, 2021
Monoclonal Gammopathy, Smoldering Multiple Myeloma Trial in United States (Daratumumab)
Active, not recruiting
- Monoclonal Gammopathy
- Smoldering Multiple Myeloma
-
Monterey, California
- +5 more
Nov 1, 2021
Screening to Improve Survival in AL Amyloidosis
Recruiting
- Smoldering Multiple Myeloma
- Monoclonal Gammopathy of Undetermined Significance
-
Orange, California
- +5 more
Nov 16, 2022
A Cohort Study of Plasma Cell Disorders (PCDs) in PKUFH
Recruiting
- Multiple Myeloma
- +11 more
- No intervention
-
Beijing, ChinaPeking University First Hospital
Apr 21, 2022
Cancer Prevention, Weight Loss, Smoldering Waldenstrom Macroglobulinemia(WM) Trial in Boston (Prolonged Fasting Intervention,
Not yet recruiting
- Cancer Prevention
- +5 more
- Prolonged Fasting Intervention
- EDUCATION CONTROL
-
Boston, MassachusettsDana Farber Cancer Institute
Dec 28, 2022
Monoclonal Gammopathy, Smoldering Myeloma, Myeloma Trial in Cleveland (DKK1)
Not yet recruiting
- Monoclonal Gammopathy
- +2 more
- DKK1
-
Cleveland, Ohio
- +1 more
Nov 29, 2021
Multiple Myeloma, Amyloidosis, Cryoglobulinemia Trial in Chapel Hill
Recruiting
- Multiple Myeloma
- +8 more
-
Chapel Hill, North CarolinaNorth Carolina Cancer Hospital
Nov 30, 2021
Plasma Cell Myeloma, Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Buffalo (behavioral, drug, other)
Recruiting
- Plasma Cell Myeloma
- +3 more
- Behavioral Intervention
- +6 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Jul 5, 2022
MGUS, SMM, and MM Patient Experience With Coronavirus 19 Survey
Recruiting
- Multiple Myeloma
- +3 more
- Questionnaire
-
Lehi, UtahHealthTree.org (Online)
Aug 2, 2021
MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular
Recruiting
- Monoclonal Gammopathy of Undetermined Significance (MGUS)
- +8 more
-
Boston, Massachusetts
- +6 more
Apr 14, 2022
Progression to Myeloma in Asymptomatic Monoclonal Gammopathies
Recruiting
- Monoclonal Gammopathy of Undetermined Significance
- Smoldering Plasma Cell Myeloma
- Biospecimen Collection
- Laboratory Biomarker Analysis
-
Houston, TexasM D Anderson Cancer Center
Oct 4, 2021
Biology and Genetics of Smouldering Myeloma
Recruiting
- Smouldering Myeloma
- +2 more
- No intervention
-
London, United KingdomUniversity College London Hospitals
Sep 15, 2021
High Risk Smoldering Multiple Myeloma Trial in New York (Ibrutinib)
Terminated
- High Risk Smoldering Multiple Myeloma
-
New York, New YorkIcahn School of Medicine at Mount Sinai
Nov 18, 2020
Smoldering Multiple Myeloma Trial in Belgium, France, Monaco (Myelogram)
Recruiting
- Smoldering Multiple Myeloma
- Myelogram
-
Bruxelles, Belgium
- +89 more
Aug 9, 2022
Monoclonal Gammopathy of Undetermined Significance and
Terminated
- Smoldering Myeloma
- Monoclonal Gammopathy of Undetermined Significance
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Mar 4, 2021
Smoldering Multiple Myeloma Trial in Spain (carfilzomib, Lenalidomide, Dexamethasone)
Active, not recruiting
- Smoldering Multiple Myeloma
- carfilzomib
- +3 more
-
Barcelona, Spain
- +15 more
Feb 15, 2021
Multiple Myeloma Trial in Austria, Germany, Israel (Denosumab 120 MG/1.7 ML Subcutaneous Solution [XGEVA], Placebo 1.7 ml
Active, not recruiting
- Multiple Myeloma
- Denosumab 120 MG/1.7 ML Subcutaneous Solution [XGEVA]
- Placebo 1.7 ml Subcutaneous Solution
-
Graz, Austria
- +9 more
Aug 24, 2022
Refractory Multiple Myeloma, Smoldering Multiple Myeloma, Stage I Multiple Myeloma Trial in Duarte (radiation, drug, procedure,
Completed
- Refractory Multiple Myeloma
- +4 more
- total marrow irradiation
- +8 more
-
Duarte, CaliforniaCity of Hope Medical Center
Feb 25, 2021
The Development and Pilot Testing ofNew MR Imaging Protocol to
Completed
- Myeloma
- +2 more
- Diffusion Weighted Magnetic Resonance Imaging (DWMRI)
- +2 more
-
Oxford, Oxfordshire, United KingdomChurchill Hospital
Feb 4, 2021
Host Microbiota and Il-17 in Favoring Multiple Myeloma
Recruiting
- Multiple Myeloma
-
Milan, Milano, ItalyIRCCS Ospedale San Raffaele
Jan 26, 2023